• Net Element specializes in mobile payments and value-added transactional services
• It provides an array of electronic payment solutions through numerous operating companies
• The company recently launched its blockchain-powered payments application

Investors looking to leverage opportunities in mobile payments and value-added transactional services need look no further than Net Element, Inc. (NASDAQ: NETE). The company specializes in these services and is strategically positioned for growth in the U.S. and emerging nations. An international technology-driven group, Net Element supports electronic payments acceptance in an omni-channel environment encompassing point-of-sale, e-commerce and mobile devices. Net Element is headquartered in North Miami Beach, Florida.

The company provides a host of electronic payment solutions via several operating companies. These include Aptito (its cloud-based restaurant and retail point-of-sale solution), Unified Payments, PayOnline, Digital Provider, Restoactive, Net Lab and SalesCentral (http://ibn.fm/gPg3C). Through these companies, Net Element’s strategy focuses on three areas of omni-channel processing – mobile payments direct carrier billing, point-of-sale solutions and payment acceptance value-added transactions.

Recently, Net Element launched a multi-channel, blockchain-powered payments acceptance application as an element of its Netevia Platform (www.Netevia.com). Netevia is a feature-ready multi-channel payments platform. It connects and streamlines payments through a single integration point. It does so while boosting the economic efficiency of all transactions made within the network. The Netevia platform supports Poynt and PAX smart payment terminals, e-commerce and in-app or online payment forms that join credit card and cryptocurrency payment methods in one simplified interface.

Utilizing Netevia’s user-friendly developer center, developers can create cryptocurrency acceptance functions to fit their requirements. Developers can also use Netevia’s API (Application Programming Interface) payment mechanism to add these functions. Therefore, broader acceptance and the widespread use of the Netevia platform offers investors an early-in opportunity to grow with Net Element.

Net Element has launched its blockchain-powered payments application across manifold outlets (http://ibn.fm/rqdGa). These touch points include face-to-face by way of smart payment terminals and electronic commerce, as well as through API. The cryptocurrency payment acceptance application is fully compliant and secure.

In a news release, Vlad Sadovskiy, Net Element’s president of integrated payments, said, “Over the past few years blockchain technology has revolutionized the world of payments thanks to its decentralization, cost-effectiveness and convenience. The addition of a cryptocurrency payment acceptance option to our Netevia platform carries forward our tradition of innovation as we power global commerce.”

With a mission of enabling its clients to conduct business worldwide, Net Element offers small to medium enterprises (SMEs) a unique mobile payments and value-added transactional services platform. For investors, the company offers growth opportunities as it works to increase transactional revenue by innovating SME productivity services through the use of diverse technology solutions and Aptito. Net Element is dynamically transforming its industry as it builds smarter point-of-sale options and delivers secure and scalable solutions.

For more information, visit the company’s website at www.NetElement.com

• CIIX recently hired Boustead Securities LLC as underwriter for the planned IPO of its wholly owned subsidiary, CBD Biotech
• Warren Wang, CEO of CIIX, said that the move is part of its strategic plan, as CIIX looks to return to its root activities in education and consulting with companies seeking to raise profile within the investment community
• Boustead Securities would serve as IPO sponsor and underwriter, CIIX said

ChineseInvestors.com, Inc.’s (OTCQB: CIIX) retention of Boustead Securities LLC for its anticipated IPO of wholly owned foreign enterprise CBD Biotech will enable the company to focus on its revenue base in video and online education, investor relations services and subscription activities. At the same time, CIIX plans to secure a separate exchange listing for CBD Biotech (http://ibn.fm/aS1BM).

In a news release, Warren Wang, CEO of CIIX, said, “Additionally, we believe that listing on a national exchange speaks to the quality of CBD Biotech, will provide us with market visibility and access to capital, and further support our growth strategy.”

Dan McClory, Boustead Securities’ managing director, head of China and head of equity capital markets, was optimistic. “We believe CBD Biotech can potentially gain a first mover advantage in the Chinese CBD market and could be well received in the public markets,” he noted in a news release.

CIIX sees CBD Biotech delivering higher CBD product distribution in FY2019, both domestically and in China. It reported an 800 percent increase in product sales led by ChineseHempOil.com, Inc. during its fiscal first quarter of 2019. CIIX recorded 70 percent higher YOY sales for the same fiscal quarter (http://ibn.fm/cGO9x).

For more information, visit the company’s website at www.ChineseInvestors.com

• Canada’s “green rush” cannabis market challenges have revealed the importance of securing product pipeline
• Icon Exploration’s pending reverse takeover of LP applicant City View Green positions it to acquire 40,000-square-foot cultivation facility
• City View Green also holds option on additional 125,000 square feet of farm and extraction space for its planned edibles, distillates and water-soluble brands

As investors and consumers alike assess the gains and losses evident during the “green rush” of 2018, when companies such as Icon Exploration Inc. (TSX.V: IEX.H) launched aggressive efforts to capitalize on changing laws and attitudes regarding cannabis, their attention is turning toward companies that can deliver revenues by ensuring a steady product pipeline (http://ibn.fm/oA42R). Icon Exploration’s efforts to create a well-diversified company focused on becoming a leading purveyor of medicinal and recreational cannabis is evidence that the company’s industry-experienced team is preparing to meet that demand.

Icon Exploration is building its portfolio with a reverse takeover of private company City View Green, an applicant for Canada’s licensed producer designation that expects to complete a 40,000-square-foot cultivation facility near Toronto for pharmaceutical-grade cannabis once the government green lights the application. Another 4.3 acres at the location is being held for possible exponential upscaling with an additional 125,000 square feet of farm and extraction facilities.

City View Green intends to use the space for cultivating its cannabis and then producing high-quality edible products, distillates and water-soluble brands for the cannabidiol (CBD)-infused beverage market, a rising sector within the industry as consumers continue to explore non-smoking ways of benefiting from cannabis’ properties.

“We’re now realizing that it isn’t only about crop yield. Over the long term, it’s about lowering production costs and developing efficient extraction and processing methodologies,” CEO Rob Fia stated in an interview with Postmedia Content Works last year (http://ibn.fm/R3ARp). “It’s also about developing consumer products focused on the retail market, because the higher margins and potential will be there, not in flower. We’re particularly strong on beverages and cosmetics derived from cannabis, infused with either CBD or THC (tetrahydrocannabinol).”

In a new show of faith in Icon Exploration’s potential, Fia updated the company’s August early warning report to note that he has recently been issued 312,500 additional common shares of Icon at a price of $0.15 per share pursuant to the exercise of share purchase warrants (http://ibn.fm/FZwhH).

The update states that Fia now has ownership and control of more than 4.6 million shares of Icon. Despite the increase in the number of his shares in the company, the report states that dilution since August 2017 has decreased his overall ownership interest from about 16.1 percent to approximately 13.9 percent of Icon’s present outstanding shares, on a non-diluted basis. On a partially diluted basis in which the exercise of all 1.3 million-plus stock options held by Fia is assumed, he would have ownership and control over about 17.3 percent of the then-issued Icon shares.

City View Green expects to employ contractors and use about half of the planned Ontario facility’s space for growing product with state-of-the-art LED lighting, HVAC systems and automation technologies designed to ensure cannabis product consistency and quality. About 4,000 square feet will be devoted to an extraction laboratory outfitted for an ultra-efficient CO2 supercritical extraction process.

City View Green is also working with other companies in the cannabis sector to establish agreements for the supply of its products once the operation gets final approval from the government.

For more information, visit the company’s website at www.IconExploration.net

• eSignature Guarantee’s platform provides an easy online method for securities holders to receive medallion signature guarantee stamps for securities transfer
• eSignature Guarantee focuses on identity verification and fraud protection
• eSignature Guarantee is the only medallion stamp provider that permits identity verification online

eSignature Guarantee is an innovative, patent-pending online platform founded by Seth Farbman, Yoel Goldfeder and Moshe Joshua. This online platform enables stockholders to obtain a signature guarantee for the transfer of securities. In addition, the platform offers the ability to sign documents with a digital signature and upload them to eSignature.

A signature guarantee is a type of authentication provided by financial institutions. This is to prevent fraud, hasten the legal transfer of securities and protect transfer agents from the legal consequences of a fraudulent signature. Essentially, a signature guarantee authenticates the signature of a person making a request to transfer physical certificates of financial instruments such as securities.

Of note is that eSignature Guarantee is the only medallion stamp provider that permits the verification of identity online. The company’s emphasis is on identity verification and fraud protection. Its platform is a combination of state-of-the-art technology with an advanced intelligence identification verification system, so individuals can prove who they are.

eSignature Guarantee offers an easy, seamless process. The first step is identity confirmation. A user simply creates an account, then proceeds with the verification process. This involves providing his or her name, address, mobile phone number, social security number and birth date to verify identity. Confirmation codes are subsequently sent to the user’s email and mobile phone, and these codes are then entered into the correct field on screen.

Upon mobile number and email address confirmation, eSignature Guarantee’s advanced intelligence engine asks a series of multiple choice questions known only to the individual. Passing the dual-verification process and having the user’s identity verified is contingent on answering the questions correctly. This stringent security process protects the individual from identity theft.

The second step in the process involves providing securities details (ownership type, type of security, etc.). Information is taken regarding the specific securities that require stamps. The individual provides supporting documentation (stock power agreements or statement of ownership), selects a shipping method and pays for the service.

eSignature Guarantee makes the process as convenient as possible via varied options. Users can upload the documents, ship them to eSignature’s offices or use a combination of the two. If uploading documents, individuals can use the company’s digital signature tools.

The checkout page is the third step in the process, after all transaction information has been entered. A confirmation code is sent to the user’s mobile phone. This code is required before entering credit card payment information. As simple as that, the transaction is complete and eSignature Guarantee will stamp and ship the securities certificates upon receiving all the supporting information.

Regarding its electronic signature offering, eSignature Guarantee works with industry leader HelloSign to provide the highest level of comfort, technology and security. Moreover, it also provides an audit trail. Of great benefit is that all HelloSign fees are covered by eSignature.

eSignature Guarantee concentrates on making the transfer of securities an uncomplicated and efficient process. Its expert staff takes users step-by-step through the identification process and diligently reviews files to expedite transfers. eSignature’s platform melds compliance and technology in tandem with an exceptional level of client service to make obtaining a medallion stamp hassle-free.

For more information, visit the company’s website at www.eSignatureGuarantee.com

• Lexaria Bioscience has its innovative DehydraTECH drug delivery platform
• The company’s DehydraTECH technology is complementary to other R&D being done on cannabinoids
• Lexaria recently attended O’Cannabiz 2018 in Vancouver

A biotech company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) offers a unique platform that makes it possible to deliver bioactive substances through oral ingestion. Its DehydraTECH technology accomplishes this without the need for unhealthy inhalational dosing. DehydraTECH uses only GRAS (Generally Recognized as Safe) ingredients and increases bio-absorption by five to 10 times. Based in Kelowna, British Columbia, Lexaria Bioscience is the only company globally with patents issued for the oral delivery of all cannabinoids.

The DehydraTECH drug delivery platform encapsulates cannabinoid compounds in a lipid molecule to eliminate undesirable tastes in cannabinoid edibles. Moreover, this improves bioavailability by protecting the cannabinoid compounds from stomach and first-pass liver metabolism (http://ibn.fm/tyvvj). The technology promotes lower overall dosing and higher effectiveness of lipophilic active molecules.

Recently, Lexaria Bioscience Chief Executive Officer Chris Bunka discussed company progress and plans at O’Cannabiz 2018 (http://ibn.fm/5uF6B). The O’Cannabiz Conference and Expo took place in Vancouver, British Columbia, in December 2018. The conference featured hundreds of international cannabis companies. Bunka noted (http://ibn.fm/ziUJo) that, in a nutshell, Lexaria makes, “…cannabis products taste better, smell better, and get into your bloodstream a lot more quickly.”

Lexaria Bioscience has provided these benefits to tea and other products. The company removes unwanted tastes as well as smells. Therefore, there is no need to add a lot of sugars or artificial ingredients to mask unpleasant flavors. Lexaria’s tea products sell as ViPova branded premium teas. The company’s other products include TurboCBD high-absorption, full spectrum hemp oil capsules.

Bunka further noted that Lexaria Bioscience has 10 patents granted with over 50 patents pending. Four of the granted patents focus on the delivery of nicotine. The company is not partnering with the tobacco industry. However, Bunka informed that Lexaria is exploring the potential use of its DehydraTECH technology to help people stop smoking.

The company’s technology has been shown to deliver nicotine to the brain quicker than traditional delivery systems. The goal for Lexaria is to put nicotine into some type of oral form to eliminate the need for inhalation and help people curb their smoking habits. DehydraTECH studies in 2018 included two animal studies that delivered pioneering results highlighting the improvements of nicotine delivery to blood plasma and across the blood-brain barrier (http://ibn.fm/QOjnR).

Lexaria Bioscience’s technology is patent protected for cannabidiol and all other non-psychoactive cannabinoids. The company has patents pending for THC, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine, other psychoactive cannabinoids and other molecules. An enabling technology and not a competing one, DehydraTECH is a complementary layer that works with the other research and development (R&D) being done on cannabinoids.

Lexaria Bioscience is on the move in its industry. The company is hiring new personnel and building a new laboratory in Canada. It recently created four new subsidiaries, which it is staffing up as well. With more growth on the horizon, Lexaria offers potential profit opportunities to investors wanting to leverage the company’s innovative DehydraTECH drug delivery platform.

For more information, visit the company’s website at www.LexariaBioscience.com

• Recent passage of 2018 Farm Bill clears way for farming of industrial hemp and production of cannabidiol (CBD)
• Photobioreactors currently used in cultivation of green algae, a high protein dietary supplement or whole food cultivated worldwide with multiple industry uses
• Project goal includes mass production of CBD from cell cultures of industrial hemp
• SinglePoint’s online CBD distribution subsidiary, SingleSeed, poised for significant growth as selection of CBD products increases in 2019
• Hemp-derived CBD market expected to reach $1.3 billion by 2022

SinglePoint, Inc. (OTCQB: SING), a fully reporting technology company providing mobile payments, blockchain solutions and ancillary cannabis services, is quickly taking advantage of its first-mover status in the CBD space with an investment in TorusMed Inc., which plans to develop CBD cell cultures from industrial hemp with photobioreactors. In a news release announcing the investment, SinglePoint said that the project’s goal is to ultimately have pharmaceutical grade CBD cultivated in a lab setting to ensure consistency of a premium product (http://ibn.fm/PUg9g).

Photobioreactors create a closed system, providing a controlled environment fed by either natural sunlight or artificial light that enables high productivity of plant cell structures. Photobioreactor systems are currently being used to produce algae, which has emerged as a popular element in industries like cosmetics, pharmaceuticals, food and beverage, biofuels, pollution control and more (http://ibn.fm/81jiv).

The recent passage of the 2018 Farm Bill, which legalized industrial hemp and removed it from the Controlled Substance Act, is good news for anyone interested in hemp, the THC-free strain of cannabis whose uses range from fibers to food to pharmaceuticals. A recent episode of Science Friday with Ira Flatow focused on farming the plant and the medical research underway studying the potential uses of CBD derived from hemp (http://ibn.fm/c51z3).

“Well, I just think that CBD is really exceptional,” Flatow’s guest, Dr. Esther Blessing, a researcher and assistant professor of psychiatry at NYU Langone Health in New York City, stated in the interview. “There’s been no other drug in the history of neuropsychiatry that has the potential to treat so many different disorders. I’m not saying that it does treat them all, but the evidence is good so far. So, it would be ideal to put aside all of these issues of legality and the fact that it comes from the cannabis plant and start to be able to treat it as a medicinal agent with controlled clinical trials and get it out to people who need it as quickly as possible.”

Teaming up with TorusMed in a project to mass cultivate CBD cell cultures using photobioreactors makes sense for SinglePoint on multiple levels. Development of pharmaceutical grade CBD that is cultivated in lab settings could potentially change the way industrial hemp and CBD are manufactured by reducing time, cost and resources while increasing consistency, safety and scalability. The project’s specific aim is to develop optimal protocols for mass CBD production from cell cultures of industrial hemp. Photobioreactors offer several advantages as compared to open-field farm cultivation, including, but not limited to, independence from weather and seasonal climatic conditions and scalable industrial and environmentally-controlled production.

SinglePoint plans to distribute the premium CBD upon completion of the development, and it is currently working with producers and manufacturers for distribution of industrial hemp CBD through its ecommerce site, SingleSeed.com. SinglePoint intends to increase revenue and sales through the subsidiary by growing its distribution to both retail and other channels.

For more information, visit the company’s website at www.SinglePoint.com

• Global market for energy-efficient buildings, products trending upward amid growing attention to climate change concerns
• Zenergy’s flagship Zero Cost Program largely responsible for company’s million-dollar year-over-year revenue growth as an energy efficiency technology provider
• Company drawing on $1.6 million in new funding with potential for up to $10 million as it advances Zero Cost Program, plans energy commodity sales

Energy consumers’ ability to efficiently manage their usage is beginning to acquire the same importance as other environmental impact and pollution reduction concerns, and next-generation energy utility companies such as Zenergy Brands, Inc. (OTC: ZNGY) are working to make a better world possible.

For years, the science community has expressed interest in evidence of changes to the earth’s climate on a significant scale. Media reports have advanced warnings about potential long-term consequences on human, plant and animal life resulting from trending changes in global surface temperature, exemplified by sizeable glacial melting at the earth’s poles (http://ibn.fm/PDsB9), an increasing severity of extreme weather conditions (http://ibn.fm/ULNTH) and rising sea levels flooding coastal real estate (http://ibn.fm/Ndd48).

An increase in greenhouse gases such as carbon dioxide, methane, nitrous oxide and fluorocarbons attributed mainly to humanity’s pollutants – particularly burned fossil fuels – gets the blame for the changing climates. Many activists have spurred governmental policies that favor pollutant reduction, such as the elimination of chlorofluorocarbons emitted into the atmosphere and the multi-national signing of the Paris Agreement accords that call for more electric vehicles to replace petroleum-fueled cars (http://ibn.fm/rmaiW).

Zenergy’s virtual utility model promotes the smart use of utilities to reduce energy consumption by eliminating wasteful behaviors. The company’s flagship technological offering, the Zero Cost Program, employs a Managed Energy Services Agreement (MESA) to deliver conservation solutions for water, gas and electrical utilities. Under the MESA, Zenergy assumes the responsibility for upfront costs related to putting the necessary equipment retrofits in place or even building them into a new structure to suit the client. The customers then pay a downward scaling part of their utility expense savings to Zenergy over the term of the contract before deciding whether to renew the contract every five to seven years.

The Zero Cost Programs’s energy-saving solutions include HVAC and refrigeration motor controllers, load factor technologies, building-envelope-based technologies, weatherization-based technologies, remote access to smart controls and LED lighting. The program is designed to reduce utility consumption by 20 to 60 percent through remote access and artificial intelligence devices for residential, commercial, industrial and municipal end-use customers alike.

As consumer awareness of climate change-related problems grows, the global market for energy-efficient building solutions is expected to increase to nearly $360.6 billion by 2026 from 2017’s reported $227.4 billion, according to a report by Navigant Research (http://ibn.fm/hpl2Y). Likewise, the energy efficient devices market is expected to grow to $908.49 billion by 2022 (http://ibn.fm/RsRMe).

The dawn of 2019 heralds a year of potential for Zenergy as it works to take advantage of a recent agreement with a fund management group. This will establish a $10 million debenture facility that provides an initial tranche of funding of $1.6 million and the remainder over the course of the arrangement through June 2021, if the lender approves it as a result of the company’s performance (http://ibn.fm/FFVtT). The company also intends to provide an in-house clientele for its Zero Cost Program by rebounding from a canceled Texas retail electric provider (REP) acquisition and re-entering the commodity sales business sometime after June as a strictly B2B platform with a new wholesale energy distribution partner, according to a statement by CEO Alex Rodriguez issued on January 7 (http://ibn.fm/oGjNc).

Zenergy’s revenues topped $1.2 million at the close of the third quarter, primarily as a result of the Zero Cost Program, according to the company’s most recent 10-Q filing, marking an exponential rise from $23,585 of the prior year (http://ibn.fm/E8kvq).

For more information, visit the company’s website at www.ZenergyBrands.com

• Supreme Cannabis recently provided a 7ACRES construction update, announcing that 19 flowering rooms have been completed and the remaining six are expected to be ready by March 2019
• The modular design of the facility enables independent adjustment of crop cultivation conditions, resulting in higher quality and better yield
• According to Supreme Cannabis, 7ACRES’ production capacity will reach 50,000 kilograms by mid-2019

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) recently announced that it has completed 19 of the 7ACRES flowering rooms and is on target to complete all 25 by March 2019. Once construction is finalized, 7ACRES will have a greenhouse footprint of nearly 300,000 square feet (http://ibn.fm/HkxFO).

Under the updated timeline provided by Supreme Cannabis, three additional flowering rooms will become operational in January, and, following completion of all 25 flowering rooms in March, the primary office and administrative areas will be finalized by the end of the first half of 2019.

The estimated annual output of Supreme Cannabis Company’s flagship brand and wholly owned subsidiary 7ACRES is on pace to reach 50,000 kilograms by mid-2019. The addition of the greenhouse flowering rooms will increase the total size of the facility to 440,000 square feet.

According to the Supreme Cannabis management team, 7ACRES is a unique facility for Canada, with an unparalleled ability to produce high-quality cannabis on a commercial scale and each flowering room utilizing sophisticated HPS lighting technology to ensure the quality of indoor lighting. The additional lights are supplementary to the sunlight entering the flowering rooms and are needed to improve terpene and cannabinoid production.

7ACRES is characterized by the modular design of each of the flowering rooms. As a result, the environmental conditions in each room can be adjusted independently of the other facility modules. The risk of losses is reduced exponentially through tailored cultivation conditions that are precisely chosen for each crop.

Any expansion of the facility is the subject of Health Canada regulatory approval. Upon completion of the flowering rooms, Supreme Cannabis plans to streamline the Health Canada review by submitting multiple rooms for simultaneous review.

“7ACRES sets the international standard for cannabis cultivation and allows us to grow craft-quality cannabis at scale,” Supreme Cannabis president and Founder John Fowler said in a news release. “We believe consumer behaviour has validated our thesis that people prefer higher-quality flower and are willing to pay more for it, and as the market expands for derivative products such as vape pens and edibles we expect consumers will prefer products extracted from the highest quality inputs.”

7ACRES is a cultivation facility that ranks among the first 40 federally licensed cannabis producers in Canada. Through a focus on scaled cannabis production, 7ACRES will enjoy a high level of flexibility as the Canadian market continues to grow.

The quality of 7ACRES’ production is one of its primary strengths, as Supreme Cannabis has noted. This high level of quality was officially recognized when 7ACRES received a ‘Brand of the Year’ award in 2018 at the Canadian Cannabis Awards (http://ibn.fm/OzjqI).

Supreme Cannabis is a Canadian publicly-traded company committed to providing premium brands and products. Its portfolio includes the wholly owned 7ACRES subsidiary, an equity investment and a long-term global distribution partnership with Lesotho-based Medigrow.

For more information, visit the company’s website at www.Supreme.ca

• Spectrum Global Solutions specializes in telecommunications via its subsidiaries
• The company engineers, upgrades, installs and maintains next-generation telecommunication networks
• Its growth strategy includes acquisitions, increasing market share and leveraging organic revenue and margin growth

Spectrum Global Solutions, Inc. (OTC: SGSI) is the holding company for next generation technology companies that specialize in telecommunications throughout the United States, Canada and the Caribbean. Via its subsidiaries, the company provides services directly to carriers, aggregators, utilities, enterprise clients, project management organizations (PMO) and original equipment manufacturers (OEM). Spectrum is one of the few engineering and installation companies that can provide all services and bundle products for telecommunications clients. Spectrum Global Solutions is headquartered in Longwood, Florida.

The company is a foremost single-source provider of end-to-end, next-generation wireless and wireline network infrastructure and professional service solutions. Its subsidiaries include AW Solutions, Inc. – Telecommunications & Engineering Services; AW Solutions Puerto Rico -Telecommunications & Engineering Services; and Tropical Communications, Inc. – Utilities. In addition, its subsidiaries include ADEX Corporation – Professional Services & Solutions, and ADEX Puerto Rico, LLC – Professional Services & Solutions.

Fundamentally, Spectrum Global Solutions engineers, upgrades, installs and maintains next-generation telecommunications networks. The company is professionally registered in 49 states, three U.S. territories (Puerto Rico, U.S. Virgin Islands and Guam) and six Canadian Provinces. Its services run the gamut from a single activity to multi-year, multi-region large scale turnkey development contracts (http://ibn.fm/s7kd2).

A projected $157 billion in U.S. telecommunication carrier capital expenditures is expected by 2021, and 5G next generation networks will be a significant part of this expenditure (http://ibn.fm/VXCUE). Spectrum Global Solutions is positioned to take advantage of this development because of its acquisitions and its experience in completing greater than 150,000 project activities on wireless, DAS, wireline and fiber networks throughout the U.S. The company’s ADEX Corp. and ADEX Puerto Rico LLC acquisitions have set Spectrum on course to benefit from the ongoing rollout of 5G services during the coming years (http://ibn.fm/wmMRA). Information Age (http://ibn.fm/OoYa6) notes that, “Not only does 5G promise to boost efficiency and unleash the potential of automation, but it will also enable us to explore developing technologies such as virtual reality (VR) and augmented reality (AR).”

A proven market operator in a high-growth telecom market segment, Spectrum Global Solutions’ growth strategy includes strategic and tactical acquisitions. Its criteria for acquisitions focus on companies with synergistic strategic value, a history of profitability and operations that are accretive to earnings and growth. Criteria also includes companies with strong management/retention, long-term customer relationships and sufficient size to add scale (http://ibn.fm/nfbOK).

The company’s growth strategy also aims to build market share and leverage organic revenue and margin growth. This involves focusing its sales team at new service provider targets, growing corporate margins and establishing new PMO and OEM partnerships. This strategy also aims to expand SGSI’s service footprint and open the door for new services, as well as maximizing cross-selling opportunities by taking advantage of its operating subsidiaries’ clients, services and relationships.

Spectrum Global Solutions, with its experienced management team, has the initiatives in place to foster shareholder growth. With client re-engagements at more than 98 percent, the company’s track record speaks for itself. Spectrum Global Solutions is ready to facilitate 5G growth as it continues to provide premier telecommunications engineering and infrastructure services to its diverse clientele.

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

• Supreme Cannabis Company focuses on growing sustainable cannabis businesses
• The company’s portfolio includes innovative 7ACRES brand
• Supreme Cannabis recently signed an agreement with Wiz Khalifa’s Khalifa Kush Enterprises

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) works to identify new opportunities to build unique cannabis businesses. The company’s 7ACRES licensed producer subsidiary operates a 440,000 sq. ft. facility in Ontario, Canada. 7ACRES’ specialty is growing high-quality cannabis in large quantities. Supreme Cannabis Company has its corporate headquarters in Toronto, Ontario.

Supreme Cannabis’ portfolio additionally includes an equity investment and long-term worldwide distribution partnership with Medigrow. This partnership is for the export of medical-grade cannabis oil. Moreover, Supreme Cannabis has partnered with a number of Canadian cannabis retailers to advance its distribution in the medical cannabis market.

7ACRES is the company’s flagship brand (http://ibn.fm/43RME). 7ACRES’ hybrid greenhouse is in Kincardine, Ontario (http://ibn.fm/YiNzO). At this facility, indoor-quality buds are produced with sun-grown characteristics. Using the full-spectrum sun, 7ACRES is the largest facility of its kind to grow with advanced HVAC and CO2 enrichment. At present, the capacity at the facility is 13,333 kilograms of dried cannabis per year. Supreme Cannabis plans to boost production by mid-2019 to a rate of 50,000 kilograms annually.

Recently, Supreme Cannabis announced an exclusive consulting agreement with Wiz Khalifa’s Khalifa Kush Enterprises (KKE). This agreement is geared toward developing and launching a line of premium cannabis products under the KKE brand into the emerging Canadian marketplace (http://ibn.fm/PSzxC). Supreme Cannabis Company’s consulting services agreement is with Khalifa Kush Enterprises Canada ULC, which is an affiliate of KKE in the U.S.

Wiz Khalifa is a Grammy Award-winning American musician and actor. He has become an icon in the cannabis community through the development of his line of regulated marijuana strains, products and concentrates under the Khalifa Kush brand. He has focused on raising awareness for the cannabis industry. In a news release, Khalifa, principal of KKE, said, “My team and I have spent the past year finding a partner that shares our vision, values, and passion for cannabis. The team at Supreme Cannabis understands the importance of high quality cannabis and how to produce [it at scale].”

Supreme Cannabis will have exclusive rights to the KKE brand within Canada. It will also have exclusive rights to potential expansion into global markets. This will depend on approval from KKE, as well as the legal status of the products in international markets. Supreme Cannabis Company President John Fowler added, “I was impressed by the quality of the ‘Khalifa Kush’ strain and the level of care and involvement Wiz had with developing the strain and working with cultivators to continue to improve quality batch-by-batch. We’re excited to be working with KKE Canada to build out another brand with the same commitment to quality.”

At the center of the cannabis space since 2014, Supreme Cannabis Company’s mission is to grow sustainable cannabis businesses. The company offers investors potential returns from the Canadian market and, in the future, beyond. As it continues to identify opportunities to build groundbreaking cannabis businesses worldwide, Supreme Cannabis is positioned at the forefront of the industry.

For more information, visit the company’s website at www.Supreme.ca